Subscribe
Sunil Verma, MD, MSEd, FRCPC, discusses the PALOMA-3 trial, which examined palbociclib with or without fulvestrant for the treatment of patients with HR-positive, HER2-negative breast cancer.
Weight Gain Risk Higher Among Breast Cancer Survivors
Sue Friedman on Informed Decision-Making in Hereditary Cancers
Melanie A. Nix Provides Advice for a New Cancer Advocate
Sue Friedman Provides an Overview of the ABOUT Network
3 Sessions are Available!
2 Sessions are Available!
Aditya Bardia, MD, MPH, FASCO; Bachar Samra, MD
Filipa Lynce, MD; Rita Nanda, MD
Aditya Bardia, MD, MPH, FASCO; Erika P. Hamilton, MD